<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="project_funders\PMC6838418\results\search\funders\results.xml">
  <result pre="(2015-02757), the Ludwig Institute for Cancer Research, Uppsala University, the" exact="Ministry of Science and Technology," post="Taiwan (106–2314-B-037-088- and 106–2915-I-037-501-), Kaohsiung Medical University Hospital (KMUH103-3 T05)"/>
  <result pre="the Ministry of Science and Technology, Taiwan (106–2314-B-037-088- and 106–2915-I-037-501-)," exact="Kaohsiung Medical University" post="Hospital (KMUH103-3 T05) and Academy of Finland. The funders played"/>
  <result pre="protocol was approved by the Institutional Review Board (IRB) of" exact="Kaohsiung Medical University" post="Hospital (IRB Number: KMUH-IRB-20110451). Informed consent was obtained from"/>
  <result pre="patients were according to the criteria defined by the 2009" exact="World Health Organization" post="(WHO) guidelines. Patients' demographic information, pre-existing diseases, clinical manifestations"/>
  <result pre="tests were performed at the Department of Laboratory Medicine of" exact="Kaohsiung Medical University" post="Hospital. Patients who only provided single samples were excluded."/>
  <result pre="infection by positive results of their nasopharyngeal swab specimens using" exact="Alere" post="BinaxNOW Influenza A&amp;amp;B Card (Alere Scarborough, Maine, USA), were"/>
  <result pre="infection were performed at the Center for Disease Control (CDC)," exact="Department of Health," post="Taiwan. Laboratory-confirmed dengue patients meant that the patient had"/>
  <result pre="ratio [43]. 2.3 Clinical definitions According to the revised 2009" exact="World Health Organization" post="(WHO) guidelines, dengue infected symptomatic patients can be categorized"/>
  <result pre="electrophoresis (SDS-PAGE), followed by wet transfer to nitrocellulose membrane (Amersham," exact="GE Healthcare," post="Sweden). Membranes were blocked in 5% BSA in Tris"/>
 </snippets>
</snippetsTree>
